Medicare Advantage coverage restrictions for the costliest physician-administered drugs.

The American journal of managed care(2022)

引用 0|浏览0
暂无评分
摘要
Four large MA insurers managed access to expensive physician-administered drugs with a combination of prior authorization, step therapy, and Part D formulary design. When a low-cost alternative exists, these tools can help reduce wasteful spending, but the administrative barriers may also reduce access.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要